I personally see this as a positive trend. VC in its earliest form was concerned with experiments that had high technology risk. I am thinking of companies like Genentech and scientists like biochemist Herbert Boyer, who had pioneered recombinant DNA technology.
After that, VC had become more like PE, investing in stuff that was working already but needed money to scale.
After that, VC had become more like PE, investing in stuff that was working already but needed money to scale.